What type of study is this?

This is a In Vitro Study study.

What question did this study set out to answer?

To explore the efficacy of hdac inhibitors in treating acute megakaryoblastic leukemia by activating apoptosis and pyroptosis.

December 8, 2025Blood

HDAC inhibitors potentiate the efficacy of antineoplastic agents in acute megakaryoblastic leukemia via dual activation of apoptosis and pyroptosis

View Full Paper

Ask AI

Bookmark

Authors

HLHu Liu

Discussion

Member takes

Overview

Research demonstrates that hdac inhibitors and antineoplastic agents activate apoptosis in acute megakaryoblastic leukemia, suggesting effective combination therapies.

Key Points

To explore the efficacy of hdac inhibitors in treating acute megakaryoblastic leukemia by activating apoptosis and pyroptosis.
Single-cell transcriptomics of pediatric amkl patients' bbmcs to identify dysregulated pathways.
Chemical library screening of about 400 compounds targeting cell death and histone modification.
Validation of hdac inhibitors' efficacy across amkl cell lines and patient samples using in vivo and in vitro assays.
RNA-seq and western blot analyses to investigate underlying mechanisms.
Hdac inhibitors induced apoptosis and pyroptosis in amkl models, confirmed through caspase-3 activation and gsdme cleavage.
Combination therapy with bcl-xl inhibitors significantly reduced tumor burden and improved survival rates in amkl models.
RNA-seq revealed key alterations in pro-apoptotic gene expression, driving cell death mechanisms.

Cite This Study

Hu Liu (2025) studied this question.

synapsesocial.com/papers/69362f3d4fa91c937236d4ba https://doi.org/10.1182/blood-2025-3243

View Full Paper

Ask AI

Bookmark

December 8, 2025Blood

HDAC inhibitors potentiate the efficacy of antineoplastic agents in acute megakaryoblastic leukemia via dual activation of apoptosis and pyroptosis

View Full Paper

Ask AI

Bookmark

Authors

HLHu Liu

Discussion

Member takes

Overview

Research demonstrates that hdac inhibitors and antineoplastic agents activate apoptosis in acute megakaryoblastic leukemia, suggesting effective combination therapies.

Key Points

To explore the efficacy of hdac inhibitors in treating acute megakaryoblastic leukemia by activating apoptosis and pyroptosis.
Single-cell transcriptomics of pediatric amkl patients' bbmcs to identify dysregulated pathways.
Chemical library screening of about 400 compounds targeting cell death and histone modification.
Validation of hdac inhibitors' efficacy across amkl cell lines and patient samples using in vivo and in vitro assays.
RNA-seq and western blot analyses to investigate underlying mechanisms.
Hdac inhibitors induced apoptosis and pyroptosis in amkl models, confirmed through caspase-3 activation and gsdme cleavage.
Combination therapy with bcl-xl inhibitors significantly reduced tumor burden and improved survival rates in amkl models.
RNA-seq revealed key alterations in pro-apoptotic gene expression, driving cell death mechanisms.

Cite This Study

Hu Liu (2025) studied this question.

synapsesocial.com/papers/69362f3d4fa91c937236d4ba https://doi.org/10.1182/blood-2025-3243

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

View Full Paper

Ask AI

Bookmark